Pabst T - Search Results

1

Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter?

Moser S, Bacher U, Jeker B, Mansouri Taleghani B, Betticher D, Ruefer A, Egger T, Novak U, Pabst T. Moser S, et al. Among authors: pabst t. Hematol Oncol. 2019 Dec;37(5):649-651. doi: 10.1002/hon.2673. Epub 2019 Sep 13. Hematol Oncol. 2019. PMID: 31483507 Free article. No abstract available.

2

Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial).

Schmid A, Friess D, Mansouri Taleghani B, Keller P, Mueller BU, Baerlocher GM, Leibundgut K, Pabst T. Schmid A, et al. Among authors: pabst t. Leuk Lymphoma. 2015 Mar;56(3):608-14. doi: 10.3109/10428194.2014.927454. Epub 2014 Aug 4. Leuk Lymphoma. 2015. PMID: 24884311 Clinical Trial.

3

Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia.

Wetzel D, Mueller BU, Mansouri Taleghani B, Baerlocher GM, Seipel K, Leibundgut K, Pabst T. Wetzel D, et al. Among authors: pabst t. Br J Haematol. 2015 Jan;168(2):268-73. doi: 10.1111/bjh.13118. Epub 2014 Sep 12. Br J Haematol. 2015. PMID: 25212255 Free article.

4

Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma.

Berger MD, Branger G, Klaeser B, Taleghani BM, Novak U, Banz Y, Mueller BU, Pabst T. Berger MD, et al. Among authors: pabst t. Hematol Oncol. 2016 Sep;34(3):133-9. doi: 10.1002/hon.2197. Epub 2015 Feb 17. Hematol Oncol. 2016. PMID: 25689832 Clinical Trial.

5

CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma.

Berger MD, Branger G, Leibundgut K, Baerlocher GM, Seipel K, Mueller BU, Gregor M, Ruefer A, Pabst T. Berger MD, et al. Among authors: pabst t. Leuk Res. 2015 Jun;39(6):561-7. doi: 10.1016/j.leukres.2015.03.004. Epub 2015 Mar 19. Leuk Res. 2015. PMID: 25890431

6

Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.

Keller S, Seipel K, Novak U, Mueller BU, Taleghani BM, Leibundgut K, Pabst T. Keller S, et al. Among authors: pabst t. Leuk Res. 2015 Jul;39(7):786-92. doi: 10.1016/j.leukres.2015.03.015. Epub 2015 Mar 28. Leuk Res. 2015. PMID: 25891070 Free article.

7

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Samaras P, Bargetzi M, Betticher DC, Duchosal MA, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Taverna C, Zander T, Renner C. Samaras P, et al. Among authors: pabst t. Swiss Med Wkly. 2015 Feb 21;145:w14100. doi: 10.4414/smw.2015.14100. eCollection 2015. Swiss Med Wkly. 2015. PMID: 25999239 Free article. Review.

8

Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity.

Mueller BU, Keller S, Seipel K, Mansouri Taleghani B, Rauch D, Betticher D, Egger T, Pabst T. Mueller BU, et al. Among authors: pabst t. Leuk Lymphoma. 2016 May;57(5):1122-9. doi: 10.3109/10428194.2015.1079315. Epub 2015 Oct 12. Leuk Lymphoma. 2016. PMID: 26294015 Free article.

9

Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.

Berger MD, Heini AD, Seipel K, Mueller B, Angelillo-Scherrer A, Pabst T. Berger MD, et al. Among authors: pabst t. Hematol Oncol. 2017 Dec;35(4):789-796. doi: 10.1002/hon.2307. Epub 2016 Jun 15. Hematol Oncol. 2017. PMID: 27301773

10

Y⁹⁰ -Ibritumomab tiuxetan (Y⁹⁰ -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).

Voegeli M, Rondeau S, Berardi Vilei S, Lerch E, Wannesson L, Pabst T, Rentschler J, Bargetzi M, Jost L, Ketterer N, Bischof Delaloye A, Ghielmini M. Voegeli M, et al. Among authors: pabst t. Hematol Oncol. 2017 Dec;35(4):576-583. doi: 10.1002/hon.2348. Epub 2016 Sep 28. Hematol Oncol. 2017. PMID: 27677906 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page